TELA Bio, Inc.

NasdaqGM TELA

TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2024: USD -35.26 M

TELA Bio, Inc. EBITDA is USD -35.26 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 6.82% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.

TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -37.85 M, a 0.46% change year over year.
TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -38.02 M, a -34.19% change year over year.
TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -28.33 M, a -20.78% change year over year.
TELA Bio, Inc. EBITDA for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -23.46 M, a -22.17% change year over year.

Key data

Date	EBITDA	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)

NasdaqGM: TELA

TELA Bio, Inc.

CEO	Mr. Antony Koblish
IPO Date	Nov. 8, 2019
Location	United States
Headquarters	1 Great Valley Parkway
Employees	227
Sector	Health Care
Industries Biotechnology

Description

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. The company markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Key trends

Past 5 years